Roof Deck Party! Join us for fun and games at Portal Playground on Sept 16th at Bayer Co.Lab Cambridge. Register: https://lu.ma/gs7ptchr
About us
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics
- Website
-
https://portal.bio/
External link for Portal
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Watertown, Massachusetts
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
134 Coolidge Ave
Watertown, Massachusetts 02472, US
Employees at Portal
Updates
-
Join us at Portal Playground for fun, games and beer garden vibes on September 16th! RSVP Required: https://lu.ma/gs7ptchr
-
-
Boosting >1 Billion cells! Our white paper with ScaleReady demonstrates robust CRISPR editing and mRNA expression with Portal's clinical boosters! https://lnkd.in/epTHwX75
-
-
Introducing our How to Train Your Cell series by Portal's CEO, Armon Sharei! In this series, we'll explore different cell engineering and cell analytics concepts, accompanied by cute cartoons. Episode 1: Making a Super Killer is out now and discusses T cell engineering strategies! https://lnkd.in/gEdp7g4N
-
Join Sophia Hirsch this afternoon as she shares Portal's latest data on iPSC, MSC and immune cell engineering at #ISSCR '24 at Poster Board 477! Our custom Pokemon cell cards will be at our poster too! Want to talk more? https://lnkd.in/e662xgSj
-
-
We're gonna be in Germany for #ISSCR 2024 next week! Grab some time to hang out with Crystal Tsui and Sophia Hirsch to learn about Portal's magical boosting abilities for engineering stem cells. https://lnkd.in/e-ApgeQc
-
-
Crystal Tsui from Portal is at #FOCIS2024! Talk to her about our latest #immune cell engineering data with gene editing and RNA applications. Clinical workflows, point-of-care solutions and, of course, cell Pokemon cards are also great topics! https://lnkd.in/ecP-sDUu
-
-
We’re making scalable, cost-effective cell therapy manufacturing possible. Read Armon Sharei, PhD (Founder and CEO, Portal) and Fred (Federico) Parietti's (Co-founder and CEO, Multiply Labs) featured interview in PharmaVoice. Thanks Michael Gibney for a fun interview and awesome story! https://lnkd.in/eN9M9d_G
Can robots break the cell therapy bottleneck?
pharmavoice.com
-
Our VP, Head of Platform Research Mathias Pawlak will be presenting on multiplexed delivery to human primary immune and stem cells in a few hours! Join us at Poster 1131 and see how new dimensions of #cellengineering are #poweredbyportal
-
-
Come catch Armon Sharei, PhD, Mathias Pawlak and Crystal Tsui at ISCT, International Society for Cell & Gene Therapy to get a Portal Cell Card! T Cell, NK, DC, Macrophage, B Cell and iPSC cards will be roaming the halls with our team. Want a longer convo? info@portal.bio. #poweredbyportal
-